61. 自己免疫性溶血性貧血 Autoimmune hemolytic anemia Clinical trials / Disease details

臨床試験数 : 137 / 薬物数 : 127 - (DrugBank : 55) / 標的遺伝子数 : 26 - 標的パスウェイ数 : 153

24 trials found

diseases per page:

Showing 1 to 10 of 24 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-001882-34-NL (EUCTR)	06/04/2021	05/01/2021	This is a Phase 3 multi-center, open-label extension study to evaluate the long-term safety and effi ...	A Phase 3 Open Label Extension Study of FostamatinibDisodium in the Treatment of Warm Antibody Autoi ...	Warm antibody autoimmune hemolytic anemia (wAIHA) MedDRA version: 20.0;Level: LLT;Classification cod ...	Product Name: Fostamatinib Disodium Product Code: R935788 INN or Proposed INN: Fostamatinib Other descri ...	Rigel Pharmaceuticals, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	90	Phase 3	Belarus;Serbia;United States;Czechia;Spain;Ukraine;Austria;Russian Federation;United Kingdom;Italy;F ...
2	EUCTR2019-001882-34-DE (EUCTR)	23/07/2020	13/01/2020	This is a Phase 3 multi-center, open-label extension study to evaluate the long-term safety and effi ...	A Phase 3 Open Label Extension Study of FostamatinibDisodium in the Treatment of Warm Antibody Autoi ...	Warm antibody autoimmune hemolytic anemia (wAIHA) MedDRA version: 20.0;Level: LLT;Classification cod ...	Product Name: Fostamatinib Disodium Product Code: R935788 INN or Proposed INN: Fostamatinib Other descri ...	Rigel Pharmaceuticals, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	90	Phase 3	Belarus;Serbia;United States;Czechia;Spain;Ukraine;Austria;Russian Federation;United Kingdom;Italy;F ...
3	EUCTR2019-001882-34-DK (EUCTR)	03/06/2020	20/01/2020	This is a Phase 3 multi-center, open-label extension study to evaluate the long-term safety and effi ...	A Phase 3 Open Label Extension Study of FostamatinibDisodium in the Treatment of Warm Antibody Autoi ...	Warm antibody autoimmune hemolytic anemia (wAIHA) MedDRA version: 20.0;Level: LLT;Classification cod ...	Product Name: Fostamatinib Disodium Product Code: R935788 INN or Proposed INN: Fostamatinib Other descri ...	Rigel Pharmaceuticals, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	81	Phase 3	Belarus;Serbia;United States;Czechia;Spain;Ukraine;Austria;Russian Federation;United Kingdom;Italy;F ...
4	EUCTR2019-001882-34-IT (EUCTR)	19/05/2020	30/07/2021	This is a Phase 3 multi-center, open-label extension study to evaluate the long-term safety and effi ...	A Phase 3 Open Label Extension Study of FostamatinibDisodium in the Treatment of Warm Antibody Autoi ...	Warm antibody autoimmune hemolytic anemia (wAIHA) MedDRA version: 20.0;Level: LLT;Classification cod ...	Product Name: Fostamatinib Disodium Product Code: [R935788] INN or Proposed INN: Fostamatinib Other desc ...	RIGEL PHARMACEUTICALS, INC.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	81	Phase 3	Belarus;United States;Czechia;Spain;Ukraine;Austria;Russian Federation;United Kingdom;Italy;France;C ...
5	EUCTR2019-001882-34-FR (EUCTR)	05/05/2020	06/02/2020	This is a Phase 3 multi-center, open-label extension study to evaluate the long-term safety and effi ...	A Phase 3 Open Label Extension Study of FostamatinibDisodium in the Treatment of Warm Antibody Autoi ...	Warm antibody autoimmune hemolytic anemia (wAIHA) MedDRA version: 20.0;Level: LLT;Classification cod ...	Product Name: Fostamatinib Disodium Product Code: R935788 INN or Proposed INN: Fostamatinib Other descri ...	Rigel Pharmaceuticals, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	81	Phase 3	United States;Serbia;Belarus;Spain;Ukraine;Austria;Russian Federation;United Kingdom;Italy;France;Cz ...
6	EUCTR2018-004774-97-NL (EUCTR)	09/04/2020	09/10/2019	This is a Phase 3 multi-center, randomized, double-blind, placebo-controlled, parallel group study t ...	A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of FostamatinibDisodium ...	Warm antibody autoimmune hemolytic anemia (wAIHA) MedDRA version: 20.0;Level: LLT;Classification cod ...	Product Name: Fostamatinib Disodium Product Code: R935788 INN or Proposed INN: Fostamatinib Other descri ...	Rigel Pharmaceuticals, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	81	Phase 3	Serbia;United States;Belarus;Spain;Ukraine;Austria;Russian Federation;Italy;United Kingdom;France;Hu ...
7	EUCTR2019-001882-34-HU (EUCTR)	25/02/2020	27/02/2020	This is a Phase 3 multi-center, open-label extension study to evaluate the long-term safety and effi ...	A Phase 3 Open Label Extension Study of FostamatinibDisodium in the Treatment of Warm Antibody Autoi ...	Warm antibody autoimmune hemolytic anemia (wAIHA) MedDRA version: 20.0;Level: LLT;Classification cod ...	Product Name: Fostamatinib Disodium Product Code: R935788 INN or Proposed INN: Fostamatinib Other descri ...	Rigel Pharmaceuticals, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	90	Phase 3	United States;Serbia;Belarus;Spain;Ukraine;Austria;Russian Federation;United Kingdom;Italy;France;Hu ...
8	EUCTR2019-001882-34-AT (EUCTR)	24/02/2020	15/01/2020	This is a Phase 3 multi-center, open-label extension study to evaluate the long-term safety and effi ...	A Phase 3 Open Label Extension Study of FostamatinibDisodium in the Treatment of Warm Antibody Autoi ...	Warm antibody autoimmune hemolytic anemia (wAIHA) MedDRA version: 20.0;Level: LLT;Classification cod ...	Product Name: Fostamatinib Disodium Product Code: R935788 INN or Proposed INN: Fostamatinib Other descri ...	Rigel Pharmaceuticals, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	90	Phase 3	United States;Serbia;Belarus;Czechia;Spain;Ukraine;Austria;Russian Federation;United Kingdom;Italy;F ...
9	EUCTR2019-001882-34-CZ (EUCTR)	30/01/2020	20/12/2019	A Phase 3 Open Label Extension Study of FostamatinibDisodium in the Treatment of Warm Antibody Autoi ...	A Phase 3 Open Label Extension Study of FostamatinibDisodium in the Treatment of Warm Antibody Autoi ...	Warm antibody autoimmune hemolytic anemia (wAIHA) MedDRA version: 20.0;Level: LLT;Classification cod ...	Product Name: Fostamatinib Disodium Product Code: R935788 INN or Proposed INN: Fostamatinib Other descri ...	Rigel Pharmaceuticals, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	90	Phase 3	United States;Serbia;Belarus;Czechia;Spain;Ukraine;Austria;Russian Federation;United Kingdom;Italy;F ...
10	EUCTR2019-001882-34-ES (EUCTR)	28/01/2020	02/12/2019	This is a Phase 3 multi-center, open-label extension study to evaluate the long-term safety and effi ...	A Phase 3 Open Label Extension Study of FostamatinibDisodium in the Treatment of Warm Antibody Autoi ...	Warm antibody autoimmune hemolytic anemia (wAIHA) MedDRA version: 20.0;Level: LLT;Classification cod ...	Product Name: Fostamatinib Disodium Product Code: R935788 INN or Proposed INN: Fostamatinib Other descri ...	Rigel Pharmaceuticals, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	81	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	Serbia;United States;Belarus;Spain;Ukraine;Austria;Russian Federation;Italy;United Kingdom;France;Hu ...

First Previous1 2 3Next Last